Effects of promethazine on the amplitude and spectral characteristics of electrocorticograms in rats
DOI:
https://doi.org/10.17072/1994-9952-2022-4-352-356Keywords:
pharmacoelectroencephalography, electrocorticography, promethazine, antihistaminesAbstract
Pharmaco-EEG is a promising method for the study of drugs aimed at identifying their specific effect on the electrophysiological activity of the brain. This method can be used both for screening of new molecules and for detecting the still unexplored effect on the central nervous system of drugs used in clinical practice for a long time. The identification of dose-dependent effects is of particular interest in the context of studying the latter, since most of the drugs affecting the CNS can be prescribed to patients in different dosages depending on the severity or nature of the disease, which is associated either with an increase in their effectiveness or with an effect on additional targets. Since most of the psychotropic or neurotropic drugs of the first generations are non-selective and can bind to a large number of targets, a study using pharmaco-EEG can reveal both the main and side dose-dependent effects. Promethazine is a first-generation antihistamine, and in addition to the blockade of H1 receptors, its effect is also due to the blockade of M-cholinergic receptors, which is why a wide range of actions of this drug is associated. In this study, the effect of promethazine at different doses (0.5 mg/kg, 5 mg/kg and 20 mg/kg) on the amplitude-spectral characteristics of electrocorticograms in rats was evaluated, followed by analysis of the principal components. As a result, it was found that promethazine has a dose-dependent increase in the values of the main component PC1, which reflects the amplitude characteristics of electrocorticographic activity. At the same time, the effects of the drug on the spectral characteristics of the recorded signals were multidirectional and did not have statistical significance.References
Borisova E. O. [Antihistamines: safe issues]. Lečebnoe delo. No 2 (2005): pp. 37-43. (In Russ.).
Dimpfel W. Pharmacological modulation of dopaminergic brain activity and its reflection in spectral fre-quencies of the rat electropharmacogram. Neuropsychobiology. V. 58, No 3-4 (2008): pp. 178-186. DOI: 10.1159/000191124.
Dimpfel W. Pharmacological classification of herbal extracts by means of comparison to spectral EEG signatures induced by synthetic drugs in the freely moving rat. J. Ethnopharmacol. V. 149, No 2 (2013): pp. 583-589. DOI: 10.1016/j.jep.2013.07.029.
Drinkenburg W.H. et al. Pharmaco-EEG Studies in Animals: A History-Based Introduction to Contempo-rary Translational Applications. Neuropsychobiology. V. 72, No 3-4 (2015): pp. 139-150. DOI: 10.1159/000443175.
Hansen I.H. et al. Pharmaco-electroencephalographic responses in the rat differ between active and inac-tive locomotor states. European Journal of Neuroscience. V. 50, No 2 (2019): pp. 1948-1971. DOI: 10.1111/ejn.14373.
Jobert M., Arns M. Pharmaco-EEG, Pharmaco-Sleep and EEG-Based Personalized Medicine. Neuropsy-chobiology. V. 72 (2015): pp. 137-138. DOI: 10.1159/000443192.
Jobert M. et al. Guidelines for the recording and evaluation of pharmaco-EEG data in man: the Interna-tional Pharmaco-EEG Society (IPEG). Neuropsychobiology. V. 66, No 4 (2012): pp. 201-220. DOI: 10.1159/000343478.
Koncz S. et al. EEG and Sleep Effects of Tramadol Suggest Potential Antidepressant Effects with Differ-ent Mechanisms of Action. Pharmaceuticals (Basel). V. 14, No 5 (2021): pp. 431. DOI: 10.3390/ph14050431.
Paalzow G.H.M., Paalzow L.K. Promethazine both facilitates and inhibits nociception in rats: Effect of the testing procedure. Psychopharmacology. V. 85 (1985): pp. 31-36. DOI: https://doi.org/10.1007/BF00427318.
Sysoev Yu.I. et al. A method for chronic registration of brain cortical electrical activity in rats. Journal of Evolutionary Biochemistry and Physiology. V. 58, No 1 (2022): pp. 292-301. DOI: 10.1134/S0022093022010252.
